1. Home
  2. LOPE vs BLLN Comparison

LOPE vs BLLN Comparison

Compare LOPE & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grand Canyon Education Inc.

LOPE

Grand Canyon Education Inc.

N/A

Current Price

$120.19

Market Cap

4.2B

Sector

Real Estate

ML Signal

N/A

Logo BillionToOne Inc.

BLLN

BillionToOne Inc.

N/A

Current Price

$105.64

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LOPE
BLLN
Founded
1949
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.6B
IPO Year
2008
2025

Fundamental Metrics

Financial Performance
Metric
LOPE
BLLN
Price
$120.19
$105.64
Analyst Decision
Strong Buy
Buy
Analyst Count
3
8
Target Price
★ $184.33
$128.29
AVG Volume (30 Days)
351.6K
★ 564.2K
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 103.40
EPS
★ 6.25
0.81
Revenue
★ $511,257,000.00
$305,112,000.00
Revenue This Year
$5.60
$51.61
Revenue Next Year
$6.15
$24.03
P/E Ratio
★ $18.83
$135.40
Revenue Growth
N/A
★ 99.97
52 Week Low
$113.84
$61.96
52 Week High
$182.16
$150.44

Technical Indicators

Market Signals
Indicator
LOPE
BLLN
Relative Strength Index (RSI) 25.95 48.22
Support Level N/A $89.26
Resistance Level $156.72 $108.50
Average True Range (ATR) 6.33 6.09
MACD -3.40 -0.45
Stochastic Oscillator 14.00 40.68

Price Performance

Historical Comparison
LOPE
BLLN

About LOPE Grand Canyon Education Inc.

Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges, both online and on the ground at its campus in Phoenix, Arizona, and at four off-site classroom andlaboratory sites. The Company generates all of its revenue through service agreements with its university partners.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: